Eligible Seniors Can Benefit from Eliquis Copay Card with Obamacare

The recent announcement by the Centers for Medicare and Medicaid Services (CMS) regarding the selection of 10 drugs for government price setting has raised concerns among pharmaceutical companies, patients, and healthcare professionals. The Inflation Reduction Act (IRA) has given CMS the power to negotiate prices for certain medications, including Eliquis, a prescription drug used to treat blood clots and atrial fibrillation.

However, experts argue that this arbitrary price-setting timeline may lead biotech companies to scale back research into experimental small-molecule treatments. John Stanford, Executive Director of Incubate Coalition, has spoken out against CMS' negotiations, stating that it would affect investment in small molecule drugs, which are often taken in pill form.

Insurance companies and their pharmacy benefit managers (PBMs) may also restrict access to medicines through increased utilization management, higher copays, and more restrictive formularies. This could have significant negative consequences for patients who rely on these medications.

Under the IRA, CMS will select up to 15 more drugs covered under Part D for negotiation in future years. The selected drugs account for $50.5 billion, or about 20%, of total Part D gross covered prescription drug costs between June 1, 2022, and May 31, 2023.

The good news is that the Eliquis copay card can help eligible seniors reduce their out-of-pocket costs for this medication. With Obamacare, many seniors are able to access affordable healthcare coverage, including prescription medications like Eliquis.

President Biden has released a statement highlighting the benefits of this new program: 'When implemented, prices on negotiated drugs will decrease for up to 9 million seniors.' The negotiations with participating drug companies will occur in 2024, and any negotiated prices will become effective beginning in 2026.

For eligible seniors who are currently paying up to $6,497 in out-of-pocket costs per year for their prescriptions, this could be a significant reduction. With the Eliquis copay card and Obamacare, many seniors may be able to access this medication at a lower cost.

It is essential for patients and healthcare professionals to stay informed about these changes and how they may affect access to medications like Eliquis. As the program unfolds, it will be crucial to monitor its impact on patient care and ensure that patients have access to the treatments they need.

Eliquis copay card obamacare